T1	Participants 53 109	type 2 diabetes inadequately controlled on basal insulin
T2	Participants 297 435	Patients inadequately controlled [glycated haemoglobin (HbA1c) >7 to ≤10% (>53 to ≤86 mmol/mol)] on basal insulin (glargine, detemir, NPH)
